Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neoplasms 5Multiple Myeloma 3Hematologic Neoplasms 3Thyroid Cancer, Papillary 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Non-Hodgkin 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Carcinoma, Anaplastic 1Rare Tumor 1Ovarian Neoplasms 1Lymphoproliferative Disorders 1Leukemia, Hairy Cell 1Laryngeal Neoplasms 1Glioma 1Erdheim-Chester Disease 1Colorectal Cancer Metastatic 1Adenocarcinoma, Follicular 1

Interventions

cobimetinib 2Vemurafenib 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Biopsy 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Erdheim-Chester Disease × Vemurafenib × Clear all
NCT05768178 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting
30 enrolled
CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡